Rentokil Initial (RTO) Common Equity (2021 - 2024)
Historic Common Equity for Rentokil Initial (RTO) over the last 4 years, with Q4 2024 value amounting to $5.4 billion.
- Rentokil Initial's Common Equity rose 695.28% to $5.4 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $5.4 billion, marking a year-over-year increase of 695.28%. This contributed to the annual value of $5.4 billion for FY2024, which is 695.28% up from last year.
- As of Q4 2024, Rentokil Initial's Common Equity stood at $5.4 billion, which was up 695.28% from $5.3 billion recorded in Q2 2024.
- In the past 5 years, Rentokil Initial's Common Equity ranged from a high of $5.4 billion in Q4 2024 and a low of $1.7 billion during Q4 2021
- For the 4-year period, Rentokil Initial's Common Equity averaged around $4.5 billion, with its median value being $5.0 billion (2023).
- As far as peak fluctuations go, Rentokil Initial's Common Equity surged by 18210.0% in 2022, and later surged by 558.41% in 2023.
- Rentokil Initial's Common Equity (Quarter) stood at $1.7 billion in 2021, then surged by 182.1% to $4.8 billion in 2022, then rose by 5.58% to $5.1 billion in 2023, then increased by 6.95% to $5.4 billion in 2024.
- Its last three reported values are $5.4 billion in Q4 2024, $5.3 billion for Q2 2024, and $5.1 billion during Q4 2023.